Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-31 to 2025-04-21
Current total value of award: $10273.38
Description: 4567781180!XOLAIR 300 MG/2 ML AUTOINJECT 2ML